Back to search

Article

The m6A Methylation Gene SNRPC can be used as a Biomarker for the Prognosis and Immunotherapy of Hepatocellular Carcinoma

2021-03-22

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> Hepatocellular carcinoma (HCC) is one of the most common malignancies in the world. Due to its complex pathogenic factors, the prognosis of HCC is poor. Therefore, a credible prognostic biomarker is urgently needed for this disease. N6-methyladenosine (m<sup>6</sup>A) RNA methylation plays an important role in the tumorigenesis, progression and prognosis of many...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
586f6e5f-26d7-5056-a307-9f804b84c2ae
DOI
10.21203/rs.3.rs-320369/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The m6A Methylation Gene SNRPC can be used as a Biomarker for the Prognosis and Immunotherapy of Hepatocellular CarcinomaDOI 10.21203/rs.3.rs-320369/v1
Select a neighboring publication to make it the new centre.